- Home
- SSBI vs ADAG Comparison
SSBI vs ADAG Comparison
Compare SSBI & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SSBI | ADAG |
|---|---|---|
| Founded | 1982 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 77.6M | 84.8M |
| IPO Year | 2006 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SSBI | ADAG |
|---|---|---|
| Price | $11.75 | $1.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 9.3K | ★ 53.1K |
| Earning Date | 01-27-2026 | 08-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $27,374,000.00 | $103,204.00 |
| Revenue This Year | N/A | $6,983.06 |
| Revenue Next Year | N/A | $36.05 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.95 | $1.30 |
| 52 Week High | $12.60 | $3.16 |
Technical Indicators
Market Signals| Indicator | SSBI | ADAG |
|---|---|---|
| Relative Strength Index (RSI) | 64.90 | 48.48 |
| Support Level | $11.33 | $1.76 |
| Resistance Level | $11.70 | $1.93 |
| Average True Range (ATR) | 0.25 | 0.14 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 77.20 | 48.94 |
Price Performance
Historical ComparisonAbout SSBI Summit State Bank
Summit State Bank provides various banking products and services to individuals and businesses in Sonoma County, California. It offers personal and business checking, money market, sweep, savings, and demand accounts; time certificates of deposit; and specialized deposit accounts, such as professional, small business packaged, tiered, and retirement plan accounts. The company also provides loans, including commercial loans and leases; lines of credit; commercial real estate, small business administration, residential mortgage, and construction loans; home equity lines of credit; and term and equipment loans, as well as loans to agriculture-related businesses.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.